Skip to main content
Clinical Trials/NCT05890222
NCT05890222
Recruiting
Not Applicable

IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion

Sangath1 site in 1 country784 target enrollmentNovember 1, 2023
ConditionsDepression

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depression
Sponsor
Sangath
Enrollment
784
Locations
1
Primary Endpoint
Effectiveness coverage
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The goal of this Hybrid Type 2 Implementation-Effectiveness Cluster Randomised Controlled Trial is to reduce the treatment gap for depression through the integrated implementation of interventions in facility and community platforms, in Goa, India. The primary question is to examine whether a community intervention ("Community Model") enhances the demand for, and improves the outcomes of, an evidence-based, brief psychological treatment for depression delivered by non-specialist health workers in primary health care facilities ("Facility Model"). Participants in the Facility Model arm will receive only a psychosocial intervention for depression (the Healthy Activity Program - HAP) while participants in the Community Model will receive both the HAP and the community intervention. We will compare the Facility Model and the Community Model to assess if the latter is superior in increasing the demand for depression treatment in primary care, increasing uptake of treatment by people with depression, increasing treatment completion rates, and reducing the severity of depression.

Registry
clinicaltrials.gov
Start Date
November 1, 2023
End Date
April 30, 2026
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sangath
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Effectiveness coverage

Time Frame: Three months post recruitment

Mean Patient Health Questionnaire 9 items (PHQ-9 score). The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.

Contact coverage

Time Frame: During recruitment

Patient Health Questionnaire 9 items (PHQ-9) score \>4. The minimum score is 0 and maximum score is 27; with higher scores indicating greater severity of depression.

Secondary Outcomes

  • Sustained effectiveness(Six months post recruitment)
  • Client Service Receipt Inventory(3- and 6- months post recruitment)
  • Remission(Six months post recruitment)
  • Response to treatment(Six months post recruitment)
  • WHO Disability Assessment Schedule (WHODAS 2.0)(Baseline, 3- and 6- months post recruitment)
  • Survey form for collecting costs of receiving HAP intervention to patients(3 months post recruitment)
  • Inventory form for collecting system-level economic costs of delivering interventions(Monthly, through study completion up to approximately 12 months)
  • Depression awareness(Baseline, 6, 12 and 18 months of implementation)
  • Perceived social support(3- and 6- months post recruitment)
  • Multidimensional Scale of Perceived Social Support (MSPSS)(Baseline, 3- and 6-months post-recruitment)
  • Treatment completion(Across 12 months of implementation)
  • Behavioral activation(Baseline, 3- and 6- months post recruitment.)

Study Sites (1)

Loading locations...

Similar Trials